Comparative Pharmacology
Head-to-head clinical analysis: ADRENACLICK versus EPIPEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADRENACLICK versus EPIPEN.
ADRENACLICK vs EPIPEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Epinephrine is a direct-acting sympathomimetic amine that acts on alpha- and beta-adrenergic receptors. Alpha-1 receptor activation causes vasoconstriction, increasing blood pressure and reducing mucosal edema. Beta-1 receptor activation increases heart rate and contractility. Beta-2 receptor activation causes bronchodilation and vasodilation.
Nonselective alpha-1, alpha-2, beta-1, beta-2, beta-3 adrenergic receptor agonist; causes vasoconstriction (alpha-1), bronchodilation (beta-2), and increased cardiac contractility and heart rate (beta-1).
100 to 200 mcg sublingually as needed for severe allergic reaction, may repeat every 5-15 minutes.
0.3 mg intramuscularly (lateral thigh) every 5-15 minutes as needed for anaphylaxis.
None Documented
None Documented
2.0-2.5 hours in adults with normal renal function; prolonged in renal impairment (up to 24 hours in anuria).
2-3 minutes (IV); clinical context: ultra-short half-life necessitates repeated doses or continuous infusion for sustained effect
Primarily renal (80-90% as unchanged drug via glomerular filtration and active tubular secretion), with 10-20% fecal via biliary elimination.
Renal (90% as metabolites, 10% unchanged); biliary/fecal (<5%)
Category C
Category C
Adrenergic Agonist
Adrenergic Agonist